Test Your Knowledge: COVID-19, MIS-C, and Long COVID in Pediatric Patients

COVID-19, the disease caused by SARS-CoV-2, has been disruptive worldwide. It was primarily a respiratory disease that affected many of the medically vulnerable, but the true impact of postacute sequelae of SARS-CoV-2 (PASC), which has been demonstrated to involve all organ systems, is now coming to light. 

Our recent issue COVID-19, MIS-C, and Long COVID in Pediatric Patients: An Update  reviews the presentation, evaluation, and management of patients with COVID-19, MIS-C, and PASC. Additionally, the current literature supporting public health measures, as well as COVID-19 vaccinations and their complications are discussed. 

Test Your Knowledge

Did you get it right? Click here to find out!

The correct answer: D.

Ready to learn more? Log in to check out our recent issue COVID-19, MIS-C, and Long COVID in Pediatric Patients: An Update.

USACS subscribers can log in or renew here.

You can earn 4 AMA PRA Category 1 Creditsâ„¢ by answering just 9 more questions! Subscribe today to review the issue and complete the 10-question quiz.

Here are a few key points:

  • SARS-CoV-2 typically leads to a less severe infection in children than in adults.11,12 (See Table 1 in the issue.)
  • It is important to ascertain the patient‘s exposure to COVID-19–positive contacts and COVID-19 vaccination history.
  • Children who should be evaluated immediately include infants aged <2 months with fever and older children with >3 days of fever, respiratory distress, or any sign of organ dysfunction, including decreased urine output.13
  • If patients with COVID-19 are well-appearing with only upper respiratory symptoms and fever, no laboratory studies are necessary.

Read the full issue and earn 4 AMA PRA Category 1 Credits™.

Leave a Reply

Your email address will not be published. Required fields are marked *